Araki, H., Tanaka, Y., Yoshida, S., Morita, Y., Kume, S., Isshiki, K., . . . Maegawa, H. (2013). Oral glucose‐stimulated serum C‐peptide predicts successful switching from insulin therapy to liraglutide monotherapy in Japanese patients with type 2 diabetes and renal impairment. Wiley-Blackwell.
Chicago Style CitationAraki, Hisazumi, et al. Oral Glucose‐stimulated Serum C‐peptide Predicts Successful Switching From Insulin Therapy to Liraglutide Monotherapy in Japanese Patients With Type 2 Diabetes and Renal Impairment. Wiley-Blackwell, 2013.
Cita MLAAraki, Hisazumi, et al. Oral Glucose‐stimulated Serum C‐peptide Predicts Successful Switching From Insulin Therapy to Liraglutide Monotherapy in Japanese Patients With Type 2 Diabetes and Renal Impairment. Wiley-Blackwell, 2013.